Government Accountability

Japan’s unprecedentedly short election campaign is causing voting delays and undermining democratic processes, raising concerns over government effectiveness and stability—issues with direct implications for America’s global partnerships.

As Federal Reserve officials debate keeping interest rates steady despite economic uncertainty, the real question is whether Washington is prioritizing political theater over the economic security of everyday Americans.

As former detainees testify, a federal judge examines whether Floridian immigration policies restrict access to legal counsel—highlighting a broader failure to uphold due process and national sovereignty.

The Ladin people, an ancient ethnic minority residing in the Dolomites and hosts to the Winter Olympics, face exclusion from official celebrations, exposing a disregard for cultural heritage and local identity amid global spectacle.

Nearly three months after fast-tracking arguments on Trump’s tariffs, the Supreme Court remains silent—igniting concerns about judicial delays undermining America’s economic defense.

Secretary of State Marco Rubio’s stark warning reveals the Trump administration’s unwavering commitment to securing America’s strategic goals in Venezuela—even if it means military intervention.

An official investigation reveals that excessive speed by the train operator caused a deadly derailment in Mexico’s Interoceanic Corridor, exposing risks in oversight and accountability that resonate with America’s infrastructure challenges.

As Argentina’s government pushes a sweeping labor reform, provincial state worker unions call a national strike, exposing the social turmoil that aggressive labor deregulation can ignite—lessons Washington must heed.

Colombian President Gustavo Petro’s upcoming meeting with Donald Trump is billed as ‘determinant’—but what does it mean for American sovereignty and regional security? We analyze the high-stakes encounter amid accusations and shifting alliances.

The Trump administration’s Medicare drug price negotiation program, touted as a win for seniors, masks deeper risks of government price controls undermining innovation and choice—are American families truly better off?